Cencora (COR) vs DataMeds AI (MEDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cencora is the larger company by market cap ($64.71 billion vs $7.7 million), about 8435.0 times the size, while DataMeds AI is growing revenue faster (+28.7% vs +9.3%). Cencora pays a dividend yielding 0.71%, while DataMeds AI does not currently pay one. Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -433.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | MEDS |
|---|---|---|
| Share price | $339.09 | $1.34 |
| Market cap | $64.71B | $7.67M |
| 1-day change | -0.63% | +84.14% |
| YTD return | +0.40% | — |
| 1-year return | -7.27% | — |
| 5-year return | +182.03% | — |
| P/E ratio (TTM) | 18.89 | — |
| Forward P/E | 15.60 | — |
| EPS (TTM) | $17.95 | $-18.39 |
| Dividend yield | 0.71% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $321.33B | $23.34M |
| Revenue growth (YoY) | +9.31% | +28.73% |
| Net income (latest FY) | $1.55B | $-101.27M |
| Gross margin | 3.57% | -27.54% |
| Operating margin | 0.82% | -401.70% |
| Net margin | 0.48% | -433.95% |
| 52-week high | $377.54 | $33.15 |
| 52-week low | $244.82 | $0.493 |
| Distance from 52-week high | -10.18% | -95.96% |
| Analyst consensus | buy | — |
| Avg. price target upside | +12.78% | — |
| Average volume | 1.29M | 8.43M |
| Shares outstanding | 190.83M | 5.72M |
| Employees | 47,000 | — |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 8435.0 times larger than DataMeds AI by market value ($64.71B vs $7.67M).
- Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -433.9 cents for DataMeds AI.
- DataMeds AI grew revenue faster in its latest fiscal year (+28.73% vs +9.31%).
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
About DataMeds AI
MEDS stock →DataMEDS AI, Inc. operates as a health IT company in the United States.
Health Care · Other Pharmaceuticals
COR vs MEDS FAQ
Which is bigger, Cencora or DataMeds AI?
Cencora (COR) is larger, with a market capitalization of $64.71B compared with $7.67M for DataMeds AI (MEDS).
Which pays a higher dividend, Cencora or DataMeds AI?
Cencora pays a dividend yielding 0.71%, while DataMeds AI does not currently pay a regular dividend.
Are Cencora and DataMeds AI in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.